BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  Myllia Biotechnology Appoints Board with Industry Leaders

  October 20, 2026

   · 

  1 min read
• Press Releases

  Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania

  October 20, 2026

   · 

  15 min read
• Press Releases

  Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study

  October 20, 2026

   · 

  7 min read
• 

  Inflammatory bowel disease

  Gilead’s ‘highly competitive’ mid-stage ulcerative colitis data ‘validate’ I&I push

  Gilead’s emvistegrast delivered greater clinical response than placebo, setting up the asset for Phase 3 testing in ulcerative colitis as well as studies in other inflammatory diseases and bolstering the company’s push beyond its HIV portfolio.

  October 20, 2026

   · 

  3 min read

   · 

  Tristan Manalac
• Press Releases

  Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy

  October 20, 2026

   · 

  7 min read
• Press Releases

  BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026

  October 20, 2026

   · 

  1 min read
• Press Releases

  3M Reports Third-Quarter 2026 Results; Raises Full-Year EPS Guidance

  October 20, 2026

   · 

  11 min read
• Press Releases

  Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study

  October 20, 2026

   · 

  5 min read
• Press Releases

  Kane Biotech Signs Distribution Agreement with The Stevens Company

  October 20, 2026

   · 

  4 min read
• Press Releases

  PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026

  October 20, 2026

   · 

  4 min read